ATE359067T1 - Zusammensetzungen zur verbesserung der immunantwort - Google Patents

Zusammensetzungen zur verbesserung der immunantwort

Info

Publication number
ATE359067T1
ATE359067T1 AT95810125T AT95810125T ATE359067T1 AT E359067 T1 ATE359067 T1 AT E359067T1 AT 95810125 T AT95810125 T AT 95810125T AT 95810125 T AT95810125 T AT 95810125T AT E359067 T1 ATE359067 T1 AT E359067T1
Authority
AT
Austria
Prior art keywords
compositions
improvement
immune response
plifas
anithine
Prior art date
Application number
AT95810125T
Other languages
English (en)
Inventor
Heinz Schneider
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26304411&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE359067(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Application granted granted Critical
Publication of ATE359067T1 publication Critical patent/ATE359067T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Transplantation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT95810125T 1994-03-01 1995-02-27 Zusammensetzungen zur verbesserung der immunantwort ATE359067T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9403935A GB9403935D0 (en) 1994-03-01 1994-03-01 Improvements in or relating to organic compounds
US08/394,872 US5731290A (en) 1994-03-01 1995-02-27 Method of improving the immune response

Publications (1)

Publication Number Publication Date
ATE359067T1 true ATE359067T1 (de) 2007-05-15

Family

ID=26304411

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95810125T ATE359067T1 (de) 1994-03-01 1995-02-27 Zusammensetzungen zur verbesserung der immunantwort

Country Status (11)

Country Link
US (1) US5731290A (de)
EP (1) EP0674902B1 (de)
JP (1) JPH07258075A (de)
AT (1) ATE359067T1 (de)
AU (1) AU698846B2 (de)
CA (1) CA2143486C (de)
DE (1) DE69535453T2 (de)
DK (1) DK0674902T3 (de)
ES (1) ES2285700T3 (de)
GB (1) GB9403935D0 (de)
PT (1) PT674902E (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6245340B1 (en) 1996-12-03 2001-06-12 Parvin Youssefyeh Method of improving the immune response and compositions therefor
EP0960572A1 (de) * 1998-05-12 1999-12-01 N.V. Nutricia Ernährungszusammensetzung zur Behandlung von Dekubitalgeschwüren
US6288116B1 (en) * 1998-05-13 2001-09-11 Novartis Nutrition Ag Method of administration of a nutritional product to a person having renal failure
US6864242B2 (en) * 2001-03-05 2005-03-08 Stephen P. Ernest Enteral formulation
DE10257360A1 (de) * 2002-12-09 2004-07-08 Fresenius Kabi Deutschland Gmbh Gastro-intestinal verabreichbare Formulierung und deren Verwendung
US7348957B2 (en) * 2003-02-14 2008-03-25 Intel Corporation Real-time dynamic design of liquid crystal display (LCD) panel power management through brightness control
WO2005023021A1 (ja) * 2003-09-02 2005-03-17 Bbk Bio Corporation ダイエット食品
US7754677B2 (en) * 2003-12-05 2010-07-13 Hill's Pet Nutrition, Inc. Composition and method for reducing diarrhea in a mammal
EP1591118A1 (de) 2004-04-27 2005-11-02 Nutri-Fit GmbH & Co. KG Verwendung von Melatonin zur Vorbeugung von postoperativen Komplikationen
AU2011221341B2 (en) * 2005-08-26 2013-11-28 Nestec S.A. Compositions and methods for improving functional vascular integrity, cellular survival and reducing apoptosis in ischemia or after ischemic episode in the brain
WO2007022991A1 (en) * 2005-08-26 2007-03-01 Nestec S.A. Compositions and methods for improving functional vascular integrity, cellular survival and reducing apoptosis in ischemia or after ischemic episode in the brain
EP1800675B1 (de) * 2005-12-23 2011-05-18 N.V. Nutricia Zusammensetzung enthaltend mehrfach ungesättigte Fettsäuren, Proteine, Mangan und/oder Molybden und Nukleotide/Nukleoside, zur Behandlung von Demenz
US9657086B2 (en) * 2010-08-24 2017-05-23 Wuhan Jiushengtang Bioengineering Co., Ltd Whole egg protein peptides, preparation method and use thereof
SG193246A1 (en) * 2011-03-31 2013-10-30 Nestec Sa Nutritional compositions for increasing arginine levels and methods of using same
JOP20190146A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
EP3668499A1 (de) 2017-08-14 2020-06-24 Axcella Health Inc. Aminosäurezusammensetzungen zur behandlung von lebererkrankungen
EP3810123A1 (de) 2018-06-20 2021-04-28 Axcella Health Inc. Zusammensetzungen und verfahren zur behandlung von fettinfiltration in muskeln

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4752618A (en) * 1984-07-12 1988-06-21 New England Deaconess Hospital Method of minimizing efects of infection through diet
ES2052066T3 (es) * 1988-10-31 1994-07-01 Sandoz Nutrition Ltd Mejoras en o relacionadas con compuestos organicos.
US5231085A (en) * 1988-10-31 1993-07-27 Sandoz Ltd. Compositions and methods for the enhancement of host defense mechanisms
US5780039A (en) * 1992-04-23 1998-07-14 Novartis Nutrition Ag Orally-ingestible nutrition compositions having improved palatability

Also Published As

Publication number Publication date
EP0674902B1 (de) 2007-04-11
CA2143486A1 (en) 1995-09-02
DE69535453D1 (de) 2007-05-24
DK0674902T3 (da) 2007-07-23
DE69535453T2 (de) 2008-01-17
AU698846B2 (en) 1998-11-12
EP0674902A1 (de) 1995-10-04
ES2285700T3 (es) 2007-11-16
CA2143486C (en) 2009-06-30
GB9403935D0 (en) 1994-04-20
AU1347995A (en) 1995-09-07
JPH07258075A (ja) 1995-10-09
US5731290A (en) 1998-03-24
PT674902E (pt) 2007-06-27

Similar Documents

Publication Publication Date Title
ATE359067T1 (de) Zusammensetzungen zur verbesserung der immunantwort
GB2272646B (en) Instrument for registration of the dental bite
DE69325091D1 (de) Ernährungsprodukt für verletzte und chirurgische patienten
AU563650B2 (en) Pharmaceutical compositions of benzothiophene derivatives
ITBO920277A0 (it) Endoprotesi per osteosintesi del femore prossimale
AU1430492A (en) Pharmaceutical composition for the treatment of gastritis
KR950010156B1 (en) Pharmaceutical dosage unit for the prevention or treatment of climacteric complaints
TW276172B (de)
EP0328634A4 (en) Pharmaceutical compositions for the treatment of psoriasis
IL111579A (en) Use of melatonin derivatives in the preparation of pharmaceutical compositions for use in treating desynchronization disorders
ES2024695B3 (es) Proceso y dispositivo para la esterilizacion de los conductos de nebulizacion y/o alimentacion de aire de los instrumentos medicos, en especial instrumentos de cirujia dental.
ES2192018T3 (es) Composicion farmaceutica que contiene estimuladores de interferon-gamma.
GR3034161T3 (en) Pharmaceutical composition for preventing or treating.
ES2150418T3 (es) Composiciones farmaceuticas que comprenden calcitonina.
ITRM910146U1 (it) Strumento chirurgico per l'introduzione di protesi peniene.
ATE245637T1 (de) Benzothiophenverbindungen, zubereitungen und verfahren
DE69940363D1 (de) Verwendung von Pferdemilch zur Herstellung einer Zusammensetzung zur Behandlung von Mund- und Zahnstörungen
ZA919682B (en) Use of a polypeptide having human interleukin 2 activity for the preparation of pharmaceutical compositions for the treatment of pneumothorax
ATE49101T1 (de) Zusammensetzungen zur desinfektion und zur sterilisation.
BR9102169A (pt) Aparelho para esterilizacao de canais dentarios
IT1244714B (it) Uso della benzidamina per il trattamento della placca dentaria
ATE74767T1 (de) Arzneimittelzusammensetzung zur behandlung des lungenverstopfens.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0674902

Country of ref document: EP

EEIH Change in the person of patent owner